KERRI ANN MAXWELL-DARBY: Open Payments
NPI 1679206890 · STAUNTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$111 in 5 payments from 5 companies in 2025. Trend: 2023 $166 · 2024 $329 · 2025 $111
Food & beverage: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: REXULTI, COBENFY, UZEDY, INGREZZA.
Industry payments across VA — which companies pay providers there.
